日本医疗保健金融解决方案市场评估：依类型、设施类型、融资类型和地区划分的机会和预测（2018-2032年）

日本医疗融资解决方案市场规模预计将从2024年的62.6亿美元成长到2032年的183.6亿美元，预测期内的年复合成长率为 14.40%。

由于技术进步、医疗成本上升以及对高效财务管理的需求不断增加，日本的医疗保健融资解决方案呈现成长趋势。人工智慧和资料分析等先进技术越来越受到医疗服务提供者的认可，增加了对创新金融解决方案的需求。

此外，日本人口老化和慢性病导致医疗成本上升，进一步增加了对高效财务管理解决方案的需求。医疗融资解决方案已成为医院和卫生系统的策略要务，因为它们寻求更高的营运效率并确保财务可持续性。此外，政府目的是加强医疗基础设施和推广先进医疗技术的措施也带来了利好。由于消费者期望的变化、监管变化以及为患者提供优质护理的需求，日本的医疗保健融资解决方案市场预计将进一步成长。此外，日本的医疗保健支出不断增加，预计未来将继续增加。

本报告调查了日本医疗保健金融解决方案市场，并提供了市场定义和概述、市场规模趋势和预测、各个细分市场的详细分析、行业结构、影响市场成长的因素分析、案例研究、竞争格局以及主要公司的概况。

目录

第1章 专案范围与定义

第2章 研究方法

第3章 执行摘要

第4章 顾客回馈

• 产品与市场讯息
• 品牌认知模式
• 做出购买决定时考虑的因素
• 隐私和监管考虑

第5章 日本医疗金融解决方案市场展望

• 市场规模分析及预测
• 市场占有率分析及预测
  • 依类型
  • 依设施类型
  • 依融资类型
  • 依地区
  • 公司占有率分析（前5名及其他）
• 市场地图分析

第6章 供需分析

第7章 价值链分析

第8章 波特五力分析

第9章 PESTLE 分析

第10章 利率/费用分析

第11章 市场动态

• 市场驱动因素
• 市场挑战

第12章 市场趋势与发展

第13章 案例研究

第14章 竞争格局

• 前5个竞争矩阵
• 五大公司的SWOT 分析
• 前10家公司的状况
  • Siemens Financial Services Inc.
  • Mitsubishi UFJ Financial Group
  • CIT Group Inc.
  • Orix Corporation
  • Sumitomo Mitsui Banking Corporation
  • Oxford Finance LLC
  • SoftBank Group Corp.
  • Mizuho Leasing Company, Limited
  • SBI Shinsei Bank, Limited
  • SLR Healthcare ABL

第15章 策略建议

第16章 关于我们/免责声明

Japan healthcare finance solutions market is projected to witness a CAGR of 14.40% during the forecast period FY2025-FY2032, growing from USD 6.26 billion in FY2024 to USD 18.36 billion in FY2032.

There is a growing trend in Japan toward healthcare finance solutions owing to technological advancements, increased expenditures on healthcare, and a growing demand for efficient management of finances. Growing acceptance of advanced technologies, such as artificial intelligence (AI) and data analytics, among healthcare service providers, increases the demand for innovative financial solutions.

Furthermore, the aging population in Japan and chronic diseases that are contributing to higher healthcare costs, further underline the need for effective financial management solutions. With hospitals and health systems seeking better operational efficiency and ensuring financial sustainability, healthcare finance solutions become indispensable tools in their strategic arsenal. It also enjoys government efforts aimed at strengthening health infrastructure and popularizing advanced medical technology. All things considered, the Japan healthcare finance solutions market has tremendous prospects for further growth, meeting shifting consumer expectations, changing regulations and offering superior care to patients. Furthermore, healthcare expenditure in Japan is constantly rising, expected to rise even further.

For instance, in September 2024, according to a summary by the Health, Labour and Welfare Ministry of Japan, Japan's healthcare costs exceeded USD 323 billion (Yen 47 trillion) in FY2023, marking the third consecutive year of record spending. Medical expenses for individuals aged 75 and older amounted to 18.8 trillion yen, a 4.5% increase from the previous year. The Ministry attributed the rise in healthcare costs to the ageing population and a surge in cases of infectious diseases such as influenza, particularly among children.

Advanced Technologies Fueling the Market Growth

Technologies such as AI, machine learning (ML), and analytics are transforming processes in financial processes within healthcare. These technologies assist providers in enhancing revenue cycle management, billing accuracy, and operating efficiency. AI can analyze numerous data to make predictions on billing trends for the patient and reduce human mistakes. This technological shift improves financial performance and allows healthcare organizations to better allocate resources, which ultimately leads to better patient care and satisfaction. As providers embrace these advanced technologies, the finance solutions market is going to continue to grow and absorb all the constant demands for efficiency and cost-effectiveness with great care for the patient.

For example, in September 2024, Royal Philips, a Japanese leader in health technology, and Jackson Health System, one of the nation's largest public health systems in the United States, announced the results of a collaborative Life Cycle Assessment (LCA) measuring the sustainability impact of transitioning to Philips next generation monitoring solutions. The Philips patient monitors, deployed as an Enterprise Monitoring as a Service (EMaaS) business model, can help reduce carbon emissions by 685.1 tons of CO2e or 47% compared to previous systems. This significant reduction also eliminates the need for an estimated 420,000 disposable AA batteries and 6.5 million sheets of paper, which can allow the health system to save USD 1.2 million over a 10-year device lifetime. These kinds of features will, in turn, help attract more people to Japanese healthcare, even people from abroad.

Rise in Healthcare Costs Augmenting Japan Healthcare Solution Market

Japan faces increasing healthcare cost pressures arising from several interdependent factors. Probably most important among them is the factor of the increasing age group within the population since a higher population segment would necessarily require more care, and often chronic disease-specific care, significantly affecting the overall healthcare finance picture. Further upward pressure comes through the upward swing in incomes, as well as technological developments that are shaping healthcare delivery. All these translate to more high-quality care and innovative treatments that are relatively more expensive. To control such a rise, the government has managed to streamline processes through various reforms in a bid to make health service delivery more efficient without necessarily lowering the standards, however, spending remains high since most medical costs are covered under universal healthcare coverage.

For instance, in December 2023, UbieHealth, a healthcare startup based in Japan, reported that Japan's healthcare expenditure has seen steady growth, with an approximate 2.2-fold increase over the past 30 years. As of fiscal year 2018, the data from 2023 shows a record high of nearly USD 393.5 billion.

Increasing Demand Due to the Aging Population Drives Market Growth

The growth of Japan's aging population further poses unique challenges to Japan healthcare finance solutions market. With an increased population with healthcare needs in geriatric and old age, which is commonly chronic, such as hypertension and diabetes, requires more comprehensive care. Consequently, the demand for effective financial solutions that can manage the complexity rises. An aging population not only means increased demand for healthcare services but also necessitates reviewing funding mechanisms, such as the Long-term Care Insurance (LTCI) system, aimed at supporting elderly citizens while reducing some financial burdens on families and the healthcare system.

The current dynamics of increasing technological advancements and increasing healthcare costs amid the aging population shape the market for Japanese healthcare finance solutions. The organizations facing such challenges are supposed to ensure efficiency through technological applications and build new financial concepts to meet demographic needs while securing sustainability in delivering healthcare services.

For example, as per the World Economic Forum (updated September 2023), more than 1 in 10 people in Japan are now aged 80 or older, and the country consistently rates as having the world's oldest population; creating a profound impact on Japan's economy, workforce, and society. Thus, healthcare is at an inevitable crunch point.

Equipment and Technology Finance Services Dominate the Market

Equipment and technology finance is an important segment of Japan healthcare finance solutions market, dominated by various factors. There is a high demand for leading-edge medical equipment such as diagnostic and imaging instruments, surgical devices, and IT equipment owing to consistent advances in medical technology and requirements for the best available healthcare facilities. These further demand financing arrangements for procuring and sustaining such cutting-edge equipment. Furthermore, automation, artificial intelligence, and robotic process automation are some of the technological advancements that make health services more efficient and effective, thus increasing the demand for financing solutions.

Government support is also key as the Japanese government actively promotes the uptake of advanced medical technologies through funding and incentives, urging healthcare facilities to invest in new equipment. Such support increases the demand for financing solutions and, in turn, sparks innovation in the sector. The final aspect is the rising healthcare expenditure driven by the aging population and rising healthcare costs, which indicates the need for efficient financial management solutions to maximize such expenses.

For instance, in September 2024, Merck and Siemens entered a strategic partnership to drive digital transformation across all three business sectors of Merck, as outlined in a newly signed Memorandum of Understanding. Under this collaboration, Siemens has been named one of Merck's global preferred suppliers for next-level automation, leveraging the Siemens Xcelerator platform to enhance global smart manufacturing. This partnership will enable Merck to adopt cutting-edge production technologies, setting new standards in modular manufacturing and further advancing the future of digital manufacturing processes. This will make health services more efficient and effective, thus increasing the demand for financing solutions.

North Region Dominates Healthcare Finance Solutions Market Share

Japan's northern region, especially Tokyo is the country's core health finance hub owing to concentrated advanced medical facilities and research institutions that require state-of-the-art financial solutions to ensure efficient management. Moreover, Tokyo has some well-known financial service providers for healthcare finance, thus creating an effective ecosystem in the region for such services. Government support and further initiatives for health infrastructure development across the region promote demand for finance solutions. Technological advancements also come into play, especially in Tokyo which is at the forefront of integrating automation, AI, and blockchain technologies for efficiency and good decision-making in healthcare finance. Healthcare expenditure in northern Japan is higher than in other regions, necessitating better management of finances to ensure costs are optimized to the minimum level.

For instance, in June 2024, Japanese technology investor SoftBank Group, which is headquartered in Tokyo, Japan, launched a joint venture with Tempus AI, opening a new tab that aims to analyze personal medical data with artificial intelligence (AI) to come up with treatment recommendations. SoftBank invested around USD 200 million in Tempus in its series G funding round in April before Tempus was listed on the Nasdaq in June. This depicts the continuous efforts being made in the northern region to improve the country's overall healthcare scenario.

Future Market Scenario (FY2025 - FY2032F)

Increased adoption of sophisticated technologies, including automation, artificial intelligence, robotic process automation, and blockchain solutions, will boost market growth.

Both developed and developing nations demand a high level of sophisticated medical equipment and technology. This demand has fostered the necessity for effective healthcare infrastructure and funding arrangements.

Government efforts to upgrade the healthcare infrastructure and advance technology will continue to propel the market further.

The aging population of Japan is leading to an increase in the demand for healthcare services and financing solutions. The increasing elderly population will increase the demand for advanced medical treatments, long-term care facilities, and home healthcare services.

Key Players Landscape and Outlook

Japan healthcare finance solutions market is known for innovation. Advanced technology converges with traditional expertise but maintains strong standards of quality while being sustainable and energy efficient. With increasing healthcare expenditure caused by the aging population and the prevalence of chronic diseases, the market needs financial solutions to promote high-end medical equipment and infrastructure investment. Technological innovations in automation and AI improve service efficiency, whereas government initiatives further facilitate adoption. In this scenario, leading players will focus on developing products, obtaining regulatory compliance, and exporting worldwide by using powerful R&D to maintain a competitive position in this constantly changing landscape.

In December 2024, GE HealthCare unveiled three new advanced deep-learning image processing and reconstruction solutions as a part of its Effortless Recon DL portfolio at the Radiological Society of North America (RSNA) 2024 Annual Meeting, in Chicago, IL. Understanding the need to improve operational efficiencies within radiology departments and the ongoing challenge of burnout experienced by clinicians, GE HealthCare developed the technologies to deliver exceptional image quality, reduce scan times, and support improved patient outcomes.

In June 2024, SLR Healthcare ABL provided a USD 7.5 million asset-based revolving credit facility to a chronic care physician services and technology company. The company offers around-the-clock medical coverage (primary care physicians, internal medicine doctors, nurse practitioners, licensed clinical social workers, etc.) for its contracted skilled nursing facility clients. In addition, the company has developed a proprietary EMR that is the only fully integrated platform in the chronic care industry where providers can collect, exchange, analyze, and act on patient data in real-time.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Voice of Customer

• 4.1. Product and Market Intelligence
• 4.2. Mode of Brand Awareness
• 4.3. Factors Considered in Purchase Decisions
  • 4.3.1. Features and Other Value-Added Service
  • 4.3.2. Impact on Patient Outcomes
  • 4.3.3. Efficiency of Solutions
  • 4.3.4. Compliance and Security
• 4.4. Consideration of Privacy and Regulations

5. Japan Healthcare Finance Solutions Market Outlook, FY2018-FY2032F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Type
    • 5.2.1.1. Equipment and Technology Finance
    • 5.2.1.2. Working Capital Finance
    • 5.2.1.3. Project Finance Solutions
    • 5.2.1.4. Corporate Lending
  • 5.2.2. By Facility Type
    • 5.2.2.1. Hospitals and Health Systems
    • 5.2.2.2. Outpatient Imaging Centers
    • 5.2.2.3. Outpatient Surgery Centers
    • 5.2.2.4. Physician Practices & Outpatient Clinics
    • 5.2.2.5. Others
  • 5.2.3. By Financing Type
    • 5.2.3.1. Debt Financing
    • 5.2.3.2. Equity Financing
    • 5.2.3.3. Leasing
    • 5.2.3.4. Invoice Financing
  • 5.2.4. By Region
    • 5.2.4.1. North [Hokkaido and Tohoku]
    • 5.2.4.2. Central [Kanto and Chubu]
    • 5.2.4.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa]
  • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 5.3. Market Map Analysis, FY2024
  • 5.3.1. By Type
  • 5.3.2. By Facility Type
  • 5.3.3. By Financing Type
  • 5.3.4. By Region

6. Demand Supply Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Interest Rate/Commission Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Case Studies

14. Competitive Landscape

• 14.1. Competition Matrix of Top 5 Market Leaders
• 14.2. SWOT Analysis for Top 5 Players
• 14.3. Key Players Landscape for Top 10 Market Players
  • 14.3.1. Siemens Financial Services Inc.
    • 14.3.1.1. Company Details
    • 14.3.1.2. Key Management Personnel
    • 14.3.1.3. Products and Services
    • 14.3.1.4. Financials (As Reported)
    • 14.3.1.5. Key Market Focus and Geographical Presence
    • 14.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 14.3.2. Mitsubishi UFJ Financial Group
  • 14.3.3. CIT Group Inc.
  • 14.3.4. Orix Corporation
  • 14.3.5. Sumitomo Mitsui Banking Corporation
  • 14.3.6. Oxford Finance LLC
  • 14.3.7. SoftBank Group Corp.
  • 14.3.8. Mizuho Leasing Company, Limited
  • 14.3.9. SBI Shinsei Bank, Limited
  • 14.3.10. SLR Healthcare ABL

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Japan Healthcare Finance Solutions Market, By Value, In USD Billion, FY2018-FY2032F
• Figure 2. Japan Healthcare Finance Solutions Market Share (%), By Type, FY2018-FY2032F
• Figure 3. Japan Healthcare Finance Solutions Market Share (%), By Facility Type, FY2018-FY2032F
• Figure 4. Japan Healthcare Finance Solutions Market Share (%), By Financing Type, FY2018-FY2032F
• Figure 5. Japan Healthcare Finance Solutions Market Share (%), By Region, FY2018-FY2032F
• Figure 6. By Type Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 7. By Facility Type Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 8. By Financing Type Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 9. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2024